Share

Scholar Rock Holding Corporation - news published 288 - readings 5.942

BACK
Scholar Rock Holding Corporation

Scholar Rock Holding Corporation

FDA Grants Priority Review for Biologics License Application (BLA) and EMA Accepts Marketing Authorisation Application (MAA) for Apitegromab as a Treatment for Spinal Muscular Atrophy

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Scholar Rock Holding Corporation published this content on March 25, 2025 , and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on March 25, 2025 at 11:32:49.457 .

Continue reading
25.03.2025
Scholar Rock Holding Corporation

Scholar Rock Holding Corporation

Initial Registration Statement for Employee Benefit Plan (Form S-8)

As filed with the Securities and Exchange Commission on February 27, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT Under The Securities Act of 1933 SCHOLAR ROCK HOLDING CORPORATION (Exact name of registrant as specified in its charter) ​ Delaware 82-3750435 (State or other jurisdiction of in ...

Continue reading
27.02.2025
Scholar Rock Holding Corporation

Scholar Rock Holding Corporation

Annual Report for Fiscal Year Ending 12-31, 2024 (Form 10-K)

Management's Discussion and Analysis of Financial Condition and Results of Operations The information contained in this section has been derived from our consolidated financial statements and should be read together with our consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K. This Annual Report on Form 10-K contains forwar ...

Continue reading
27.02.2025